We are live on ! Find out more
PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Paratek Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 66 → 0 (-66)

100% less capital invested

Capital invested by funds: $47M → $0 (-$47M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 66

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
–
Holders Change
-66
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
66
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$113K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NAM
Nexpoint Asset Management
Texas
-$5.52M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$4.92M
3
GAI
General American Investors
New York
-$4.07M
4
RSCM
Rock Springs Capital Management
Maryland
-$3.83M
5
BC
Bruce & Co
Illinois
-$3.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
– -$32.4K -14,668 Closed
CL
52
CSS LLC
Illinois
– -$30.9K -14,000 Closed
PCM
53
Perkins Capital Management
Minnesota
– -$30K -13,700 Closed
C
54
Covestor
United Kingdom
– -$25K -11,184 Closed
LPL Financial
55
LPL Financial
California
– -$23.4K -10,605 Closed
Baird Financial Group
56
Baird Financial Group
Wisconsin
– -$23.1K -10,435 Closed
KWM
57
Kingsview Wealth Management
Oregon
– -$22.1K -10,000 Closed
UBS Group
58
UBS Group
Switzerland
– -$18.3K -8,284 Closed
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
– -$10K -4,776 Closed
Osaic Holdings
60
Osaic Holdings
Arizona
– -$9.47K -4,292 Closed
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
– -$2.46K -1,112 Closed
PA
62
Parallel Advisors
California
– -$1.66K -750 Closed
Fidelity Investments
63
Fidelity Investments
Massachusetts
– -$928 -420 Closed
TRCT
64
Tower Research Capital (TRC)
New York
– -$221 -100 Closed
Simplex Trading
65
Simplex Trading
Illinois
– -$48 -22 Closed
HI
66
Harbour Investments
Wisconsin
– -$4 -2 Closed
1 2
3

PRTK Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q3 2023, worth a combined $0 — down 100% from $47M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of PRTK and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Nexpoint Asset Management, exiting entirely with an estimated $5.52M sold.

  • 0 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q3 2023, down from 66 in Q2 2023.
  • Funds reported $0 of Paratek Pharmaceuticals, Inc. stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Paratek Pharmaceuticals, Inc. positions in Q3 2023 and 66 closed out, a net change of -66 holders.
  • The largest Paratek Pharmaceuticals, Inc. seller in Q3 2023 was Nexpoint Asset Management, an estimated $5.52M sold.

Based on aggregated 13F filings for Q3 2023.